NCT05672914 Intervening to Promote Tobacco Cessation Following Psychiatric Hospitalization
| NCT ID | NCT05672914 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Texas at Austin |
| Condition | Smoking Cessation |
| Study Type | INTERVENTIONAL |
| Enrollment | 250 participants |
| Start Date | 2023-08-10 |
| Primary Completion | 2026-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 250 participants in total. It began in 2023-08-10 with a primary completion date of 2026-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Cigarette smoking is the leading cause of death and disability in the United States. People with psychiatric disorders consume almost half (44.3%) of all cigarettes smoked in the U.S. and have life spans more than 20 years shorter than the general population. Effective quit smoking treatments for people with psychiatric disorders are sorely needed. When patients are hospitalized for a psychiatric disorder, they are not allowed to smoke. This enforced period of no smoking creates what professionals call "a teachable moment". It provides an excellent opportunity to discuss the prospect of staying quit once the individual leaves the hospital. In ongoing research, the investigators have developed and tested a Sustained Care quit smoking intervention for smokers engaged in a psychiatric hospitalization. The intervention includes: 1) a professionally-led, motivational counseling session to encourage quitting smoking and increase awareness about available quit smoking resources, 2) a referral to the Texas Tobacco Quitline for phone-based, quit smoking counseling, and 3) an offer of 8 weeks of nicotine patches after leaving the hospital. Findings from a recently completed clinical trial provide strong support for this Sustained Care intervention. Aims in the current project are to develop and test a tablet computer-based, motivational counseling intervention that does not require a trained professional counselor. The goal is to conduct a clinical trial to demonstrate the effectiveness of this tablet-based, Sustained Care intervention for smokers engaged in psychiatric hospitalization. As before, the same quit smoking resources (Quitline and nicotine patches) will be provided upon hospital discharge. If successful, next steps will involve plans to implement this quit smoking intervention in psychiatric hospitals throughout Texas, in order to reduce the burden caused by tobacco-related cancers among the citizens of Texas.
Eligibility Criteria
Inclusion Criteria: * Male or female patients above the age of 18 capable of providing informed consent * Current smoker (at least 5 cigarettes/day when not hospitalized) * Willing and able to provide informed consent, attend all study visits, and comply with the protocol Exclusion Criteria: * Mini-Mental State Examination (MMSE) score \< 24 * Current diagnosis of dementia or other cognitive impairment that would limit study participation * Inability to provide consent for study participation due to his/her inability to demonstrate an understanding of study procedures * Current diagnosis of a (non-nicotine) substance use disorder requiring detoxification * No access to or inability to communicate by phone, or no stable mailing address * Planned discharge to institutional care (e.g., nursing home, long-term rehabilitation, jail, etc.) * Medical contraindication to nicotine patch use * Currently pregnant or breastfeeding
Contact & Investigator
Richard Brown, Ph.D.
PRINCIPAL INVESTIGATOR
The University of Texas at Austin
Frequently Asked Questions
Who can join the NCT05672914 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Smoking Cessation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05672914 currently recruiting?
Yes, NCT05672914 is actively recruiting participants. Contact the research team at brown2@utexas.edu for enrollment information.
Where is the NCT05672914 trial being conducted?
This trial is being conducted at Austin, United States.
Who is sponsoring the NCT05672914 clinical trial?
NCT05672914 is sponsored by University of Texas at Austin. The principal investigator is Richard Brown, Ph.D. at The University of Texas at Austin. The trial plans to enroll 250 participants.